ARTHEx Biotech

ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing antisense RNA treatments against genetic diseases. Our team has a strong background on drug discovery and microRNAs involvement in neuromuscular diseases. We are supported by world-renowned scientific and clinical advisors that will facilitate the successful development of our products.

ARTHEx Biotech headquartered in Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $1.6B in funding across 24 round(s). With a team of 1-10 employees, ARTHEx Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - ARTHEx Biotech, raised $46.5M. Discover more about their projects, partnerships, and impact on our platform.